EWGSOP2肌少症算法与住院老年患者住院时长的逐步关联
在意大利维罗纳大学医院老年科连续入院的604例65至99岁住院老年患者中,应用EWGSOP2指南逐步诊断肌少症,发现SARC-F风险筛查阳性者占56.0%,肌少症总患病率为22%,且肌少症患者住院中位时间(13天)长于肌张力低下者(12天)和非肌少症者(11天),算法每一步均与不良临床结局关联增强。
要点
- 住院老年患者中SARC-F提示肌少症风险者占56.0%,总肌少症患病率为22%。
- 肌少症患者住院中位13天,长于肌张力低下者12天和非肌少症者11天。
- EWGSOP2算法每一步均逐步增强对不良临床结局的预测能力。
核心结论
- EWGSOP2算法在住院老年患者中有效,每一步均增强对不良临床结局的预测能力。
- 当无身体成分数据时,SARC-F和肌肉力量仍是有价值的阴性临床结局工具。
研究设计与样本
- 所有患者接受完整老年综合评估和临床评估,并按EWGSOP2指南诊断肌少症。
主要发现
- 604例住院老年患者中,56.0%的SARC-F评分提示肌少症风险。
- 有握力数据的肌少症风险患者中,85.5%为可能肌少症。
- 有可能肌少症且有身体成分数据的患者中,83.1%确诊肌少症,总患病率为22%。
- 非肌少症患者住院中位时间最短为11天,肌张力低下者为12天,肌少症者为13天,调整年龄、营养状态和共病后差异仍显著。
- 按EWGSOP2算法每一步分为阴性和阳性后,每一步均与不良临床结局的关联逐步增大。
关键数值与推荐
- SARC-F评分提示肌少症风险者占56.0%。
- 肌少症风险且有好握力数据者中85.5%为可能肌少症。
- 可能肌少症且有身体成分数据者中83.1%确诊肌少症,总患病率22%。
- 非肌少症、肌张力低下和肌少症患者住院中位时间分别为11天、12天和13天。
临床怎么用
- 对住院老年患者可应用EWGSOP2算法逐步评估肌少症,每一步均有助于预测不良临床结局。
- 在无法获取身体成分数据时,仍可使用SARC-F和肌肉力量评估阴性临床结局风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: An international consensus is still lacking on the best operational definition of Sarcopenia in hospitalized older adults. The main objective of this study was to use the EWGSOP2 guidelines in hospitalized old subjects to test its predictivity for adverse clinical outcomes and to evaluate its step-by-step capability to predict unfavorable clinical events. PARTICIPANTS AND SETTING: Three hundred and seventeen men and two hundred and eighty seven women, aged 65 to 99 years, consecutively admitted to the Department of Geriatrics at the University Hospital of Verona. METHODS: All patients underwent a complete geriatric assessment, clinical evaluation, and for the diagnosis of Sarcopenia, the EWGSOP2 guidelines were applied. As clinical outcomes, length of hospital stay, fall risk, and subjects' quality of life were considered. RESULTS: Among 604 hospitalized older patients, 56.0% presented with a SARC-F score suggestive of a risk for Sarcopenia. Patients at risk for Sarcopenia, and with available handgrip strength data, in 85.5% of cases also presented probable Sarcopenia. Among patients with probable Sarcopenia, and with available body composition data, 83.1% were confirmed with Sarcopenia, with a general prevalence of Sarcopenia of 22%. The shortest average length of hospitalization was in non-sarcopenic patients, with a median of 11 days, whereas dynapenic and sarcopenic subjects have respectively a median of 12 and 13 days of hospitalization, with significant differences also after adjustment for age, nutritional status and comorbidity. After dividing the patients into negative or positive for each diagnostic step of the EWGSOP2 algorithm, we found, for each step of the algorithm, a progressively greater association with adverse clinical outcomes. CONCLUSIONS: EWGSOP2 algorithm is a valid tool even in hospitalized older patients, and each step enhances the predictivity of the algorithm; however, SARC-F and muscle strength can still be valuable tools for negative clinical outcomes when body composition data are not available.
引用
- Zoico E, Urbani S, Giani A, et al. European Working Group on Sarcopenia in Older People Algorithm: Step-by-Step Relation With Length of Hospitalization. J Am Geriatr Soc. 2026. PMID: 41645663. doi:10.1111/jgs.70312
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。